ArticleFrontiers in medicine2025
Transfer deep learning and explainable AI framework for brain tumor and Alzheimer's detection across multiple datasets.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Alzheimer's disease detection from structural brain MRI using FFA U-Net segmentation and transfer learning.Frontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The pressing need for accurate diagnostic tools in the medical field, particularly for diseases such as brain tumors and Alzheimer's, poses significant challenges to timely and effective treatment. Methods: This study presents a novel approach to MRI image classification by integrating transfer learning with Explainable AI (XAI) techniques. The proposed method utilizes a hybrid CNN-VGG16 model, which leverages pre-trained features from the VGG16 architecture to enhance classification performance across three distinct MRI datasets: brain tumor classification, Alzheimer's disease detection, and a third dataset of brain tumors. A comprehensive preprocessing pipeline ensures optimal input quality and variability, including image normalization, resizing, and data augmentation. Results: The model achieves accuracy rates of 94% on the brain tumor dataset, 81% on the augmented Alzheimer dataset, and 93% on the third dataset, underscoring its capability to differentiate various neurological conditions. Furthermore, the integration of SHapley Additive exPlanations (SHAP) provides a transparent view of the model's decision-making process, allowing clinicians to understand which regions of the MRI scans contribute to the classification outcomes. Discussion: This research demonstrates the potential of combining advanced deep learning techniques with explainability to improve diagnostic accuracy and trust in AI applications within healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.